AEye, Inc.
LIDR, LIDRW · Motor Vehicle Parts & Accessories · 46.3M shares · -48%/yr ↓ buyback · EDGAR filings ↗
Grade
F35Cash-depleted early-stage lidar company with negative gross margins and essentially no runway.
Strengths
- Modest revenue growth (15%, 68th pct) and high current/quick ratios on a tiny base
- Long-standing IP and Tier 1 (Continental) relationship
Risks
- Only ~$86k cash with effectively zero runway (1st pct) — acute funding crisis
- Negative gross margin (-138%) and net margin (-146%); $407M accumulated deficit
- Dependent on near-term dilutive capital raises to continue operating
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Net lossNet loss (net margin -14574.2%)
- Cash burnNegative free cash flow (-27.9M)
- Buying back stockNet buyback — share count -48%/yr over 4y
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
-137.8%
Operating margin
-13618.5%
Net margin
-14574.2%
Return on equity
-41.7%
Return on assets
-37.4%
Revenue growth (QoQ)
4.1%
Current ratio
10.5×
Free cash flow
-$28M
EBITDA
-$32M
Tangible book value
$81M
Cash & investments
$86K
Cash runway
0q
Stock comp / revenue
2370.0%
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06241664 ↗ | Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images Diabetic Retinopathy, DR, Diabetic Mellitus | NA | Completed | 2024-10-02 |
| NCT05857943 ↗ | Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images Diabetes Mellitus, Diabetic Retinopathy | NA | Completed | 2023-09-11 |
| NCT04612868 ↗ | Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images Diabetes Mellitus, Diabetic Retinopathy | NA | Completed | 2021-11-28 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-03 | Exec/director changeExhibits | filing ↗ |
| 2026-05-15 | Exec/director changeExhibits | filing ↗ |
| 2026-05-13 | ResultsExhibits | filing ↗ |
| 2026-05-12 | Shareholder vote | filing ↗ |
| 2026-05-06 | Exec/director change | filing ↗ |
| 2026-03-16 | ResultsExhibits | filing ↗ |
| 2026-02-11 | Exec/director changeExhibits | filing ↗ |
| 2025-12-10 | 1.02OtherExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-03 | 2026-06-01 | 0001213900-26-064835 ↗ |
| 8-K | 2026-05-15 | 2026-05-13 | 0001213900-26-057703 ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | 0001437749-26-017094 ↗ |
| 8-K | 2026-05-13 | 2026-05-13 | 0001213900-26-055802 ↗ |
| 8-K | 2026-05-12 | 2026-05-12 | 0001213900-26-055184 ↗ |
| 8-K | 2026-05-06 | 2026-05-04 | 0001213900-26-052513 ↗ |
| 10-K | 2026-03-18 | 2025-12-31 | 0001437749-26-008858 ↗ |
| 8-K | 2026-03-16 | 2026-03-16 | 0001213900-26-028340 ↗ |
| 8-K | 2026-02-11 | 2026-02-09 | 0001213900-26-014883 ↗ |
| 8-K | 2025-12-10 | 2025-12-10 | 0000947871-25-001074 ↗ |
| 8-K | 2025-12-04 | 2025-12-04 | 0001213900-25-118273 ↗ |
| 10-Q | 2025-11-07 | 2025-09-30 | 0001437749-25-033677 ↗ |